Translational Andrology and Urology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2024-08-19 ms5000002126430453 来自重庆

偏重的研究方向：泌尿系统肿瘤
经验分享：请问UR从step2变成step4是什么意思哇

59 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2024-06-11 ms4000001085685957 来自四川省

孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。

95 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2020-09-17 吴祥坤

大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊

166 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2024-05-05 ms2000001607118312 来自四川省

请问under review (step 1)是外审还是内审呢？

84 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2023-12-28 ms7000000355041363 来自河北省

fb

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2021-10-08 ztycycy1434

awaiting assignment8天了，这个杂志这么慢的吗？

127 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2021-09-29 ms2175991881802670

不知道是属于哪个区的期刊

143 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2021-12-28 rayms

什么是Protocol？

112 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2021-12-28 rayms

什么是comment？

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221280, encodeId=7a85222128081, content=偏重的研究方向：泌尿系统肿瘤 经验分享：请问UR从step2变成step4是什么意思哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Aug 19 11:21:25 CST 2024, time=2024-08-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2209438, encodeId=eb902209438d7, content=孟德尔返修已经等了四周了，还没有动静。有点小焦虑。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fadf9173934, createdName=ms4000001085685957, createdTime=Tue Jun 11 23:48:37 CST 2024, time=2024-06-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=886190, encodeId=5d44886190db, content=大修，但只有一个审稿人意见，是不是还得继续等更多的审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZnVUJ5coSu74OEYC0yo9pypKZhSRRxgbn91XYr3FfgdHujrjKHx9Fxl2fbOOELXmVAksZpRECGQ/132, createdBy=4c452305979, createdName=吴祥坤, createdTime=Thu Sep 17 22:02:59 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201841, encodeId=20e2220184185, content=请问under review (step 1)是外审还是内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14275422976, createdName=ms2000001607118312, createdTime=Sun May 05 15:45:52 CST 2024, time=2024-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177675, encodeId=a5e421e767517, content=fb, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b5b8764714, createdName=ms7000000355041363, createdTime=Thu Dec 28 08:42:17 CST 2023, time=2023-12-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1058731, encodeId=cdcb1058e3137, content=awaiting assignment8天了，这个杂志这么慢的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwCyp5IMOzrZnyRf4YKSHkTrdgzlJGA8ibTVxY2OJXFH3Cpxxef19Wxjo4ALWVwtkQjgmcCuvpeP4/0, createdBy=02aa1743798, createdName=ztycycy1434, createdTime=Fri Oct 08 21:54:27 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056121, encodeId=778610561219b, content=不知道是属于哪个区的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ce8GfSmiapBfpJIiblUAd85FicfEDs0ZvXAz6J3qn3q0E6SAg43lhDDqKCibbhv4zWiaibQ9m9MibZ0wOeceIR1Brshiaw/132, createdBy=ad765278140, createdName=ms2175991881802670, createdTime=Wed Sep 29 14:46:37 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110768, encodeId=9bb71110e684a, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110767, encodeId=07f31110e67d1, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:54 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896426, encodeId=421389642667, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201102/fbc9b86c51e44ef582ca872942cf41a9/227c0d5e34364fde8d73407b1fbcc881.jpg, createdBy=de422288298, createdName=121de766m53(暂无昵称), createdTime=Mon Nov 02 22:51:02 CST 2020, time=2020-11-02, status=1, ipAttribution=)]

2020-11-02 121de766m53(暂无昵称)

审稿速度:3.0 | 投稿命中率:75.0
经验分享：投了篇被拒了9次的临床回顾性文章，一审不到3个月，提的问题也比较简单，修回10天后接收

0 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务